TIDMMHC
RNS Number : 1317Z
MyHealthChecked PLC
11 May 2023
MyHealthChecked PLC
("MyHealthChecked" or the "Company")
Results of Annual General Meeting and Share Consolidation
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, is pleased to announce that at the Annual
General Meeting of the Company held earlier today (the "Annual
General Meeting"), all resolutions put to the Company's
shareholders ("Shareholders") were duly passed.
Resolution Votes for(1) % of shares Votes against(3) % of shares
(*indicates special voted(2) voted
resolution)
Resolution 1 204,958,197 99.56% 900,830 0.44%
------------- ------------ ----------------- ------------
Resolution 2 204,500,059 99.36% 1,313,830 0.64%
------------- ------------ ----------------- ------------
Resolution 3 204,389,188 99.33% 1,373,108 0.67%
------------- ------------ ----------------- ------------
Resolution 4 204,389,188 99.33% 1,373,108 0.67%
------------- ------------ ----------------- ------------
Resolution 5 200,495,999 97.44% 5,266,297 2.56%
------------- ------------ ----------------- ------------
Resolution 6 173,511,875 84.30% 32,305,086 15.70%
------------- ------------ ----------------- ------------
Resolution 7* 173,231,351 84.18% 32,543,888 15.82%
------------- ------------ ----------------- ------------
Resolution 8 176,698,162 85.86% 29,110,675 14.14%
------------- ------------ ----------------- ------------
Resolution 9* 173,000,463 84.06% 32,808,374 15.94%
------------- ------------ ----------------- ------------
Resolution 10* 173,336,748 84.21% 32,498,793 15.79%
------------- ------------ ----------------- ------------
Notes :
(1) Any proxy appointments which gave discretion to the Chairman
have been included in the "for" total.
(2) As a percentage of the aggregate of votes "for" plus votes
"against".
(3) An abstention is not counted towards the votes cast "for" or
"against" a resolution.
The full text of, inter alia, the resolutions proposed and
passed at the Annual General Meeting can be found in the Company's
Shareholder Circular and Notice of Annual General Meeting (the
"Circular") which was published and posted to Shareholders on 3
April 2023 and is available on the Company's website at
https://investors.myhealthchecked.com/
Share Consolidation
At the Annual General Meeting, Shareholders approved, inter
alia, the Share Consolidation, as detailed in the Circular.
The Share Consolidation consists of a consolidation of the
ordinary shares of GBP0.001 each in the capital of the Company (the
"Ordinary Shares"), such that every 15 Ordinary Shares will be
consolidated into one new ordinary share of GBP0.015 nominal value
each (the "Consolidated Ordinary Shares").
Following the Share Consolidation, the Company will have a
single class of ordinary shares of GBP0.015 each in issue, being
the Consolidated Ordinary Shares.
Admission of the Consolidated Ordinary Shares to trading on
AIM
Application has been made to the London Stock Exchange plc for
the admission to trading on AIM of the Consolidated Ordinary
Shares, which is expected to become effective and dealings commence
at 8.00 a.m. on or around 12 May 2023 (the "Consolidation
Admission").
Total Voting Rights, ISIN, SEDOL and Par Value
The Consolidated Ordinary Shares have a new ISIN and SEDOL code,
and the number of total voting rights in the Company's issued
ordinary share capital will decrease as a result of the Share
Consolidation.
Accordingly, upon the Consolidation Admission, the Company's
issued share capital will consist of 52,005,932 Consolidated
Ordinary Shares each with one voting right. The Company does not
hold any ordinary shares in treasury. This figure may be used by
Shareholders in the Company as the denominator for the calculation
by which they may determine if they are required to notify their
interest in, or change to their interest in, the share capital of
the Company under the FCA's Disclosure Guidance and Transparency
Rules. In addition, the ISIN and SEDOL code of the Consolidated
Ordinary Shares will be GB00BN7K5L93 and BN7K5L9, respectively.
Unless otherwise defined, capitalised terms used in this
announcement have the same meanings as ascribed to them in the
Circular sent to Shareholders dated 3 April 2023.
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014, as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018, as amended.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home
rapid tests, as well as DNA, RNA and blood sample collection kits
which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, and the sample
collection kits enable the collection of blood, urine nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests will also be made available online
and will be viable for over-the -counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGMZGMKGMRGFZM
(END) Dow Jones Newswires
May 11, 2023 06:19 ET (10:19 GMT)
MyHealthChecked (AQSE:MHC.GB)
過去 株価チャート
から 10 2024 まで 11 2024
MyHealthChecked (AQSE:MHC.GB)
過去 株価チャート
から 11 2023 まで 11 2024
